FDA Responds to Stakeholder Questions About Complying With the Agency’s Final Rule on LDTs
July 24, 2024 at 03:10 PM EST
The FDA has provided new sets of frequently asked questions (FAQs) and answers in response to inquiries that it has received related to its regulation of laboratory developed tests (LDTs).
The agency published answers to “common questions” about LDTs on July 22 as the clock continued to tick toward the beginning of the multi-stage phaseout of the agency’s general enforcement ... Read More
